Michael A. Van Ameringen

Statistics

Publications

Citations

369

H-Index

Active since

2000

Affiliations

Pfizer (United States)(Current)

Michael A. Van Ameringen is an author at Pfizer (United States) specializing in pharmacotherapy, double-blind trials, and selective serotonin reuptake inhibitor use.

Publications per year

2000–2002

Publications

Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

Michael A. Van Ameringen, Roger Lane, John R. Walker et al. · American Journal of Psychiatry · 2001 · 225 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Prevention of Relapse in Generalized Social Phobia: Results of a 24-Week Study in Responders to 20 Weeks of Sertraline Treatment

John R. Walker, Michael A. Van Ameringen, Richard P. Swinson et al. · Journal of Clinical Psychopharmacology · 2000 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment Study

Richard Bergeron, Arun Ravindran, Yves Chaput et al. · Journal of Clinical Psychopharmacology · 2002 · 60 citations

Medicine, Pharmacotherapy, Psychiatry +17

1–3 of 3